Synthesis and Characterization of Glycol Chitosan DNA Nanoparticles for Retinal Gene Delivery
- 7 November 2013
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 9 (1) , 189-196
Abstract
Given the number of monogenic ocular diseases and the number of non‐monogenic degenerative ocular diseases for which gene therapy is considered as a treatment, the development of effective therapeutic delivery strategies for DNA is a critical research goal. In this work, nonviral nanoparticles (NPs) composed of glycol chitosan (GCS) and plasmid DNA (pDNA) were generated, characterized, and evaluated. These particles are stable, do not aggregate in saline, are resistant to DNases, and have a hydrodynamic diameter of approximately 250 nm. Furthermore, the plasmid in these NPs was shown to maintain its proper conformation and can be released and expressed inside the cell. To determine whether these NPs would be suitable for intraocular use, pDNA carrying the ubiquitously expressed CBA‐eGFP expression cassette was compacted and subretinally injected into adult wild‐type albino mice. At day 14 post‐injection (PI), substantial green fluorescent protein (GFP) expression was observed exclusively in the retinal pigment epithelium (RPE) in eyes treated with GCS NPs but not in those treated with uncompacted pDNA or vehicle (saline). No signs of gross retinal toxicity were observed, and at 30 days PI, there was no difference in electroretinogram function between GCS NP‐, pDNA‐, or vehicle‐treated eyes. These results suggest that with further development, GCS NPs could be a useful addition to the available repertoire of genetic therapies for the treatment of RPE‐associated diseases.Keywords
This publication has 52 references indexed in Scilit:
- Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-l-lysineBiomaterials, 2012
- An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug deliveryBiomaterials, 2012
- Highly compacted DNA nanoparticles with low MW PEG coatings: In vitro, ex vivo and in vivo evaluationJournal of Controlled Release, 2012
- Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cellsBiomaterials, 2011
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kineticsProceedings of the National Academy of Sciences, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetateMolecular Genetics and Metabolism, 2008
- Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cellsProceedings of the National Academy of Sciences, 2007